MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acsmedchemlett.6c00017

Медицинская библиотека · ACS medicinal chemistry letters · 2026

Discovery of 5‑Azaindole Inhibitors of O‑GlcNAcase for the Treatment of Alzheimer's Disease and Related Tauopathies.

Bouton Jakob, Bretteville Alexis, Tresadern Gary, Shaffer Paul, Austin Nigel, Buijnsters Peter, Cedervall E Peder, Darville Nicolas, Fonteyn Ineke, Leenaerts Joseph, Lamenca Carolina Martínez, Mertens Liesbeth, Peeters Daniele, Velter Adriana I, Roosbroeck Yves Van, Ebneth Andreas, Bartolomé Jose Manuel, Trabanco Andrés A, Oehlrich Daniel

СтатьяПеревод пока не подготовлен

Аннотация

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by extracellular amyloid-β plaque accumulation and intracellular tau neurofibrillary tangles, with tau pathology correlating more closely with cognitive decline. Modulation of tau phosphorylation through the regulation of O-GlcNAcylation, a post-translational modification controlled by O-GlcNAcase (OGA), represents a promising therapeutic strategy. In this study, we report the optimization of a pyrimidine hit identified by high-throughput screening, leading to the discovery and optimization of a novel series of 5-azaindole-based OGA inhibitors. From this series, compound 24 was identified as an in vivo tool candidate that demonstrated a favorable pharmacokinetic profile and measurable brain exposure. Pharmacodynamic studies in murine models demonstrated that compound 24 induced a significant and transient elevation of brain O-GlcNAcylation levels, confirming the in vivo target engagement. These findings underscore the potential of 5-azaindole-based OGA inhibitors as a novel validated chemotype for modulation of O-GlcNAcylation.

Для цитирования: Bouton Jakob, Bretteville Alexis, Tresadern Gary, Shaffer Paul, Austin Nigel, Buijnsters Peter, Cedervall E Peder, Darville Nicolas, Fonteyn Ineke, Leenaerts Joseph, Lamenca Carolina Martínez, Mertens Liesbeth, Peeters Daniele, Velter Adriana I, Roosbroeck Yves Van, Ebneth Andreas, Bartolomé Jose Manuel, Trabanco Andrés A, Oehlrich Daniel. Discovery of 5‑Azaindole Inhibitors of O‑GlcNAcase for the Treatment of Alzheimer's Disease and Related Tauopathies.. ACS medicinal chemistry letters. 2026. DOI: 10.1021/acsmedchemlett.6c00017.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.